Chapter PDF
Literatur
Ammon Cavanaugh S von (1984) Diagnosing depression in the hospitalized patient with chronic medical illness. J Clin Psychiatry 45:13–16
Ammon Cavanaugh S von (1995) Depression in the medically ill. Critical issues in diagnostic assessment. Psychosomatics 36:48–59
Ananth J (1974) Antiasthmatic effect of amitriptyline. Can Med Assoc J 110:1133
Ananth J, Swartz R, Burgoyne K et al. (1994) Hepatic disease and psychiatric illness. Psychother Psychosom 62:146–159
Andersen J, Aabro E, Gulman N (1980) Antidepressant treatment in parkinson’s disease. Acta Neurol Scand 62:210–219
Aronoff G, Bergstrom R, Pottratz S et al. (1984) Fluoxetine kinetics and protein binding in normal and impaired renal function. Clin Pharmacol Ther 36:138–144
Baldessarini RJ (1996) Drugs and the treatment of psychiatric disorders. Depression and mania. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill, New York, p 431
Bandelow B, Rüther E (1993) Besonderheiten der Psychopharmakatherapie bei psychisch Kranken mit körperlichen Erkrankungen. In:Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen. Enke, Stuttgart, S 791–800
Bass S, Colebatch H (1992) Fluoxetine-induced lung damage (letter). Med J Aust 156:364–365
Beckson M, Cummings JL (1992) Neuropsychiatric aspects of stroke. Int J Psychiatry Med 21:1–15
Beitman BD, Mukerji J, Lamberti JW et al. (1989) Panic disorder in patients with chest pain and angiographically normal coronary arteries.Am J Cardiol 63:1399–1403
Bergstrom R, Beasley C, Levy N et al. (1993) The effect of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine. Int Clin Psychopharmacol 8:261–266
Berrios GE, Quemada JI (1990) Depressive illness in multiple sclerosis. Br J Psychiatry 156:10–16
Beutel M, Weiner H (1993) Trauer und Depression nach einem Objektverlust. Forum Psychoanal 9:224–239
Bigger JT, Fleiss JL, Steinman RC et al. (1992) Frequency domain measures of heart rate period variability and mortality after myocardial infarction. Circulation 85:164–171
Bishay NR, Tarrier N, Roberts AP (1995) Cognitive therapy of agoraphobia in reaction to physical illness: An uncontrolled study. Ir J Psychol Med 12:135–138
Blackwell B (1981) Adverse effects of antidepressant drugs. Drugs 21:201–219
Bluestine S, Lesko L (1994) Psychotropic medications in oncology and in AIDS patients.Adv Psychosom Med 21:107–137
Borson S, McDonald G, Gayle T et al. (1992) Improvement in mood, physical symptoms, and functions with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 33:190–201
Bouckoms A, Hackett TP (1991) The pain patient: Evaluation and treatment. In: Cassem N (ed) Massachusetts General Hospital Handbook of General Hospital Psychiatry, 3rd edn. Mosby Year Book, St. Louis, pp 39–68
Brosen K (1996) Are pharmacokinetic drug interactions with the SSRI an issue? Int Clin Psychopharmacol 11(Suppl 1):23–27
Brown JH, Paraskevas F (1982) Cancer and depression: Cancer presenting with depressive illness: An autoimmune disease? Br J Psychiatry 141:227–232
Brown RG, MacCarthy B, Gotham AM et al. (1988) Depression and disability in Parkinson’s disease. Psychol Med 18:49–55
Brown TM, Stoudemire A, Fogel BS, Moran MG (2000) Psychopharmacology in the medical patient. In: Stoudemire A, Fogel BS Greenberg DB (eds) Psychiatric care of the medical patient. 2nd edn. Oxford University Press, Oxford, pp 329–372
Bukberg J, Penman D, Holland JS (1984) Depression in hospitalized cancer patients. Psychosom Med 46:199–212
Burvill PW, Johnson GA, Vamrozik KD et al. (1995) Anxiety disorders after stroke: Results from the Perth Community Stroke Study. Br J Psychiatry 166:328–332
Callies AL, Popkin MK (1987) Antidepressant treatment in medical-surgical inpatients by nonpsychiatric physicians. Arch Gen Psychiatry 44:157–160
Cassem EH (1988) Depression secondary to medical illness. Rev Psychiatry 7:256–273
Cassem EH (1990) Depression and anxiety secondary to medical illness. Psychiatr Clin North Am 13:597–612
Cassem EH (1995) Depressive disorders in the medically ill. Psychosomatics 36:2–10
Castiella A, Arenas J (1994) Fluoxetine hepatotoxicity (letter). Am J Gastroenterol 89:458–459
Chiarello RJ, Cole JO (1987) The use of psychostimulants in general psychiatry: A reconsideration. Arch Gen Psychiatry 44:286–295
Chochinov HM, Wilson KG, Enns M et al. (1994) Prevalence of depression in the terminally ill: Effects of diagnostic criteria and symptom threshold judgements. Am J Psychiatry 4:537–540
Ciraulo DA, Shader RI (1990a) Fluoxetine drug-drug interactions, I. Antidepressants and antipsychotics. J Clin Psychopharmacol 10:48–50
Ciraulo DA, Shader RI (1990b) Fluoxetine drug-drug interactions, II. J Clin Psychopharmacol 10:213–217
Clark DC, von Ammon Cavanaugh S, Gibbons RD (1983) The core symptoms of depression in medical and psychiatric patients. J Nerv Ment Dis 171:705–713
Clark DA, Cook A, Snow D (1998) Depressive symptom differences in hospitalized, medically ill, depressed psychiatric inpatients and nonmedical controls. J Abnorm Psychol 107:38–48
Clayton PJ, Lewis CE (1981) The significance of secondary depression. J Affect Disord 3:25–35
Cohen-Cole SA, Stoudemire A (1987) Major depression and physical illness. Special considerations in diagnosis and biologic treatment. Psychiatr Clin North Am 10:1–17
Colon EA, Popkin MK (1996) Anxiety and panic. In: Randell JR, Wise MG (eds) Textbook of consultation-liaison psychiatry. American Psychiatric Press, Washington/DC, pp 402–425
Costa D, Mogos I, Toma T (1985) Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand 72(Suppl 329):85–92
Coulehan JI, Schulberg HC, Block MR, Zettler-Segal M (1988) Symptom patterns of depression in ambulatory medical and psychiatric patients. J Nerv Ment Dis 176:284–288
Craven JL, Rodin GM, Johnson L, Kennedy SH (1987) The diagnosis of major depression in renal dialysis patients. Psychosom Med 49:482–492
Creed F (1997) Assessing depression in the context of physical illness. In: Robertson MM, Katona CLE (eds) Depression and physical illness. Wiley & Sons, Chichester, pp 3–19
Cull A (1990) Invited review: Psychological aspects of cancer and chemotherapy. J Psychosom Res 34:129–140
Cummings JL (1992) Depression and Parkinson’s disease. Am J Psychiatry 149:443–454
Dalack GW, Roose SP (1990) Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 51(Suppl):4–9
Dawling S, Lynn K, Rosser R et al. (1982) Nortriptyline metabolism in chronic renal failure: Metabolite elimination. Clin Pharmacol Ther 32:322–329
De Vito AJ (1990) Dyspnoe during hospitalizations for acute phase of illness as recalled by patients with chronic obstructive airway disease. Heart Lung 19:186–191
Derogatis LR, Wise TN (eds) (1989) Anxiety and depressive disorders in the medical patient. American Psychiatric Press, Washington, DC
Derogatis LR, Morrow GR, Fetting J et al. (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757
Deshpande SN, Sundaram KR, Wig NN (1989) Psychiatric disorders among medical inpatients in an Indian hospital. Br J Psychiatry 154:504–509
Dew MA, Ragi MV, Nimorwicz P (1990) Infection with human immunodeficiency virus and vulnerability to psychiatric distress. Arch Gen Psychiatry 47:737–744
Dietch J (1981) Diagnosis of organic anxiety. Psychosomatics 22:661–665
Dietch J, Fine M (1990) The effect of nortriptyline in elderly patients with cardiac conduction disease. J Clin Psychiatry 51:65–67
Doyle G, Laher M, Kelly J et al. (1989) The pharmacokinetics of paroxetine in renal impairment. Acta Psychiatr Scand 80(Suppl 350):89–90
Drossman DA, Thompson WG (1992) The irritable bowel syndrome: Review and a graduated multicomponent treatment approach. Ann Intern Med 116:1009–1016
Ehrentraut S, Rothenhäusler HB, Gerber A, Rau HG, Thiel M, Schirren CA (2000) Akutes Leberversagen unter Nefazodon-Therapie? Nervenarzt 73:686–689
Eilenberg MD (1960) Psychiatric illness and pernicious anemia. J Ment Sci 106:1539–1548
Epstein SA (1994) Psychotropic medications in gastrointestinal and hepatic disease. In: Silver P (ed) Psychotropic drug use in the medically ill. Adv Psychosom Med, vol 21. Karger, Basel, pp 49–60
Ereshefsky L (1996) Drug interactions of antidepressants. Psychiatr Ann 26:342–350
Evans M, Hammond M, Wilson K et al. (1997) Placebo-controlled treamtent trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry 12:817–824
Fava GA (1994) Affective disorders and endocrine disease. New insights from psychosomatic studies. Psychosomatics 35:341–353
Fava GA, Molnar G (1987) Criteria for diagnosing depression in the setting of medical disesase. Psychother Psychosom 48:21–25
Fava GA, Sonino N (1996) Depression associated with medical illness. CNS Drugs 5:175–189
Fava GA, Sonino N, Morphy MA (1993) Psychosomatic view of endocrine disorders. Psychother Psychosom 59:20–33
Fava GA, Trombini G, Barbara L et al. (1985) Depression and gastrointestinal illness: The joint use of biological and clinical criteria. Am J Gastroenterol. 80:195–199
Fava GA, Sonino N, Wise TN (1988) Management of depression in medical patients. Psychother Psychosom 49:81–102
Fava M, Rosenbaum JF, Pava J et al. (1993) Anger attacks in unipolar depression, part 1: Clinical correlates and response to fluoxetine treatment. Am J Psychiatry 150:1153–1163
Fawzy FI, Fawzy NW, Hyun CS et al. (1993) Malignant melanome: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50:681–689
Fawzy FI, Fawzy NW, Canada AL (1998) Psychosocial treatment of cancer: An update. Curr Opin Psychiatry 11:601–605
Feldman E, Mayou R, Hawton K et al. (1987) Psychiatric disorder in medical inpatients. QJM 63:405–412
Fernandes NF, Martin RR, Schenker S (2000) Trazodone-induced hepatotoxicity. A case report with comment on drug-induced hepatotoxicity. Am J Gastroenterol 95:532–538
Fifer SK, Mathias SD, Patrick DL et al. (1994) Untreated anxiety among adult primary care patients in a health maintenance organization. Arch Gen Psychiatry 51:740–750
Fogel BS (1990) Major depression versus organic mood disorder: A questionable distinction. J Clin Psychiatry 51:53–56
Folstein SE, Abbott MH, Chase GA et al. (1983) Huntington’s disease in a case series and in a family. Psychol Med 13:537–542
Ford MF (1986) Treatment of depression in Huntington’s disease with monoamine oxidase inhibitors. Br J Psychiatry 149:654–656
Frank RG, Beck NC, Parker JC et al. (1988) Depression in rheumatoid arthritis. J Rheumatol 15:920–925
Frasure-Smith N (1991) In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction in men. Am J Cardiol 67:121–127
Frasure-Smith N, Lesperance F, Talajic M (1993) Depression following myocardial infarction, impact on 6-month survival. JAMA 270:1819–1825
Freedland KE, Carney RM, Lustman PJ et al. (1992) Major depression in coronary artery disease patients with vs. without prior history of depression. Psychosom Med 54:416–421
Gellert GA, Maxwell RM, Siegel BS (1993) Survival of breast cancer patients receiving adjunctive psychosocial support therapy: A 10-year follow-up study. J Clin Oncol 11:66–69
Goldberg RJ, Posner DA (1993) Anxiety in the medically ill. In: Stoudemire A, Fogel BS (eds) Psychiatric care of the medical patient. Oxford University Press, New York, pp 87–104
Gonzalez-Rothi R, Zander D, Ros P (1995) Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. Chest 107:1763–1765
Goodnick PJ (1994) The pharmacokinetic optimization of treatment with newer antidepressants. Clin Pharmacokinet 27:307–330
Gore-Felton C, Spiegel D (2000) Group psychotherapy for medically ill patients. In: Stoudemire A, Fogel BS, Greenberg DB (eds) Psychiatric care of the medical patient. 2nd edn. Oxford University Press, Oxford, pp 41–49
Greer S (1994) Psycho-oncology: Its aims, achievements, and future tasks. Psychooncology 3:87–101
Guthrie E (1996) Emotional disorders in chronic illness: Psychotherapeutic interventions. Br J Psychiatry 168:265–273
Haggerty JJ, Drossman DA (1985) Use of psychotropic drugs in patients with peptic ulcer. Psychosomatics 26:277–284
Hama N, Boumpas DTD (1995) Cerebral lupus erythematosus. CNS Drugs 3:416–426
Harrison J, Maguire P (1994) Predictors of psychiatric morbidity in cancer patients. Br J Psychiatry 165:593–598
Hayward C, Clark DB, Taylor CB et al. (1990) Panic disorder, anxiety, and cardiovascular risk. In: Ballenger JC (ed) Clinical aspects of panic disorder. Wiley-Liss, New York, pp 99–110
Henry JA (1989) A fatal toxicity index for antidepressant poisoning. Acta Psychiatr Scand 80:37–45
Hinrichsen GA, Liebermann JA, Pollack S et al. (1989) Depression in hemodialysis patients. Psychosomatics 30:284–289
Holland JC, Hughes A, Korzan AH et al. (1986) Comparative psychological disturbance in patients with pancreatic and gastric cancer. Am J Psychiatry 143:982–986
Holliday SM, Benfield P (1995) Venlafaxine A review of its pharmacology and therapeutic potential in depression. Drugs 49:280–294
Horowitz MJ (1976) Stress response syndromes. Jason Aronson, New York
Horowitz MJ, Siegel B, Holen A et al. (1997) Diagnostic criteria for complicated grief disorder. Am J Psychiatry 154:904–910
Hughes JE (1985) Depressive illness and lung cancer. Eur J Surg Oncol 11:15–20
Judd FK, Mijch AM (1994) Depression in patients with HIV and AIDS. Aust NZ. J Psychiatry 28:642–650
Kaasa S, Malt U, Jagen S et al. (1993) Psychological distress in cancer patients with advanced disease. Radiotherp Oncol 27:192–197
Kapfhammer HP (1993a) Epidemiologie der Depression im Rahmen von Tumorerkrankungen. In: Staab HJ, Ludwig M (Hrsg) Depression bei Tumorpatienten. Thieme, Stuttgart, S 29–41
Kapfhammer HP (1993b) Nieren-und leberinsuffiziente Patienten — ein therapeutisches Problem. In: Möller HJ, Przuntek H (Hrsg) Therapie im Grenzgebiet von Psychiatrie und Neurologie. Springer, Berlin Heidelberg New York Tokyo, S 75–92
Kapfhammer HP (1995) Benzodiazepine bei Angsterkrankungen. In: Kasper S, Möller HJ (Hrsg) Praxis der Angst-und Panikerkrankungen. Fischer, Stuttgart, S 261–288
Kapfhammer HP (1996) Depression und Suizidalität bei Krebserkrankungen. TW Neurologie Psychiatrie 10:281–283
Kapfhammer HP (1998) Internistische Aspekte der Behandlung mit Antidepressiva. In: Hewer W, Lederbogen F (Hrsg) Internistische Probleme bei psychiatrischen Erkrankungen. Enke, Stuttgart, S 51–87
Kapfhammer HP (1999) Psychopharmakotherapie depressiver Störungen bei somatischen Erkrankungen mit selektiven Serotonin-Wiederaufnahmehemmern, anderen neueren Antidepressiva und amphetaminergen Substanzen. In: Diefenbacher A (Hrsg) Aktuelle Konsiliarpsychiatrie und-psychotherapie. Thieme, Stuttgart, S 131–160
Kapfhammer HP (2001) Begleitdepression bei körperlichen Krankheiten: Epidemiologie und Diagnostik. Jatros Neurologie/Psychiatrie (Sonderpublikation):6–17
Kapfhammer HP (2002) Organisch depressive Störungen: Koronare Herzerkrankung, Diabetes mellitus, Krebs. In: Laux G (Hrsg) Depression 2000. Springer, Berlin Heidelberg New York Tokyo, S 65–86
Kapfhammer HP, Rothenäusler HB, Krauseneck T, Stoll C, Schelling G (2001) Posttraumatische Belastungsstörung bei Patienten mit ARDS. Jahrbuch der Medizinischen Psychologie 20. Hogrefe, Göttingern, Bern, Toronto, Seattle, S 119–138
Kathol RG, Wenzel RP (1992) Natural history of symptoms of depression and anxiety during inpatient treatment on general medicine wards. J Gen Int Med 7:287–293
Kathol RG, Turner R, Delahunt J (1986) Depression and anxiety associated with hyperthyroidism: Response to antithyroid therapy. Psychosomatics 27:501–505
Kathol RG, Mulgi A, Williams J et al. (1990) Diagnoss of major depression in cancer patients according to four stes of criteria. Am J Psychiatry 1021–1024
Katon W (1998) The effect of major depression on chronic medical illness. Semin Clin Neuropsychiatry 2:82–86
Katon W, Sullivan DM (1990) Depression and chronic medical illness, J Clin Psychiatry 51(Suppl 6):3–11
Katon W, Berg AO, Robins AJ, Risse S (1986) Depression: Medical utilization and somatization. West J Med 114:564–568
Katz IR (1996) On the inseparability of mental and physical health in aged persons. Am J Geriatr Psychiatry 4:1–6
Klein DF (1993) False suffocation alarms, spontaneous panics, and related conditions: An integrative hypothesis. Arch Gen Psychiatry 50:306–317
Klein E, Cnaani E, Harel T et al.(1995) Altered heart rate variability in panic disorder patients. Biol Psychiatry 37:18–24
Klerman GL (1981) Depression in the medically ill. Psychiatr Clin North Am 4:301–317
Koenig HG, Breitner JCC (1990) Use of antidepressants in medically old patients. Psychosomatics 31:22–32
Koenig HG, Meador KG, Cohen HJ et al. (1988) Self-rated depression scales and screening for major depression in the older hospitalized patient with medical illness. J Am Geriatr Med 36:699–706
Koenig HG, Georage LK, Meador KG (1997) Use of antidepressants by nonpsychiatrists in the treatment of medically ill hospitalized depressed elderly patients. Am J Psychiatry 154:1369–1375
Koenig HG, Pappas P, Hoslinger T et al. (1995) Assessing diagnostic approaches to depression in medically ill older adults: How reliably can mental health professions make judgements about the cause or symptoms? J Am Geriatr Soc 43:472–478
Korff M von, Shapiro S, Burke JD et al. (1987) Anxiety and depression in a primary care clinic: Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. Arch Gen Psychiatry 44:152–156
Korff M von, Ormel H, Katon W et al. (1992) Disability and depression among high utilizers of health care: A longitudinal analysis. Arch Gen Psychiatry 49:91–100
Larcombe NA, Wilson PH (1984) An evaluation of cognitive behavior therapy for depression in patients with multiple sclerosis. Br J Psychiatry 145:366–371
Leipzig RM (1990) Psychopharmacology in patients with hepatic and gastrointestinal disease. Int J Psychiatry Med 22:109–139
Lesko LM, Massie MJ, Holland J (1993) Oncology. In: Stoudemire A, Fogel (eds) Psychiatric care of the medical patient. Oxford University Press, Oxford New York Toronto, pp 565–590
Levenson H, Hales RE (1993) Brief psychodynamically informed therapy for medically ill patients. In: Stoudemire A, Fogel BS (eds) Medical-psychiatric practice, vol 2. American Psychiatric Press, Washington/DC London, pp3–37
Levenson H, Servis M, Hales RE (2000) Brief psychodynamic therapy in the medically ill. In: Stoudemire A, Fogel BS, Greenberg DB (eds) Psychiatric care of the medical patient. 2nd edn. Oxford University Press, Oxford, pp 17–30
Levenson J (1992) Psychosocial interventions in chronic medical illness. Gen Hosp Psychiatry 14:43–49
Levenson JL, Bemis C (1991) The role of psychological factors in cancer onset and progression. Psychosomatics 32:124–132
Levenson JL, Friedel RO (1985) Major depression in patients with cardiac disease. Psychosomatics 26:91–102
Levy N (1990) Psychopharmacology in patients with renal failure. Int J Psychiatry Med 20:325–334
Liang LP, Dunn SM, Gorman A, Stuart-Harris R (1990) Identifying priorities of psychoocial need in cancer patients. Br J Cancer 62:1000–1003
Lieberman JA, Cooper TB, Suckow RW et al. (1985) Tricyclic antidepressant and metabolite levels in chronic renal failure. Clin Pharmacol Ther 37:301–307
Light RW, Merrill EJ, Despars J et al. (1986) Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch Intern Med 146:1377–1380
Lipowski Z (1990) Delirium: Acute confusional states. Oxford University Press, New York Oxford
Lipowski ZJ (1975) Physical illness, the patient and his environment. In: Reiser M (ed) American handbook of psychiatry, vol 4. Basic Books, New York, pp 3–42
Lipsey JR, Robinson RG, Pearlson GD et al. (1984) Nortriptyline treatment of post-stroke depression. Lancet i:297–300
Lishman WA (1987, 31998) Organic psychiatry. The psychological consequences of cerebral disorder, 2nd edn. Blackwell, Abingdon
Lloyd GG, Cawley RH (1978) Psychiatric morbidity in men one week after first acute myocardial infarction. Br J Med 2:1453–1454
Lustman PJ, Griffith LS, Clouse RE et al. (1997) Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial. Psychosom Med 59:241–250
Maricle RA, Hosenpud JD, Norman DJ et al. (1989) Depression in patients being evaluated for heart transplantation. Gen Hosp Psychiatry 11:418–424
Maguire P, Haddad P (1996) Psychological reactions to physical reactions. In: Guthrie E, Creed F (eds) Seminars in liaison psychiatry. Royal College of Psychiatrists, Gaskell Glasgow, pp 157–191
Maguire GP, Julier DL, Hawton KE et al. (1974) Psychiatric morbidity and referral on two general medical wards. Br Med J:268–270
Maguire GP, Lee EG, Bevington DJ et al. (1978) Psychiatric problems in the first year after mastectomy. Br Med J:963–965
Manoach M, Varon D, Neumann M et al. (1989) The cardioprotective features of tricyclic antidepressants. Gen Pharmacol 20:269–275
Masand P, Pickett P, Murray G (1991) Psychostimulants for secondary depression in medical illness. Psychosomatics 32:203–208
Massie MJ, Holland JC (1990) Depression and the cancer patient. J Clin Psychiatry 51(Suppl 7):12–19
Mayeux T (1990) Depression in the patient with Parkinson’s disease. J Clin Psychiatry 51:20–23
Mayou RA, Sharpe M (1995) Psychiatric illness associated with physical disease. Baillieres Clin Psychiatry 1:201–223
Mayou R, Hawton K, Feldman E (1988) What happens to medical patients with psychiatric disorder? J Psychosom Res 32:541–549
Meares RA, Mills JE, Horvath TB (1971) Amitriptyline and asthma. Med J Aust 2:25–28
Moffic HS, Paykel ES (1975) Depression in medical in-patients. Br J Psychiatry 126:346–353
Möller HJ (1996) Forschungsstandort Deutschland: Klinische Entwicklung neuer Antidepressiva. Psycho 22:147–157
Montgomery SA (1995) Safety of mirtazapine: A review. Int Clin Psychopharmacol 10(Suppl 2):37–45
Morris PL, Robinson RG, Andrzejewski P et al. (1993) Association of depression with 10 year post-stroke mortality. Am J Psychiatry 150:124–129
Morrison MF, Kastenberg JS (1997) Differentiation of secondary from primary mood dissorders: Controversies and consensus. Semin Clini Neuropsychiatry 2:232–243
Müller N, Kapfhammer HP, Spatz R, Hippius H (1995) Lithiumprophylaxe: Hohe Effizienz und geringes Risiko bei regelmäßiger Überwachung. Dtsch Ärztebl 92:A365–A369
Murray GB, Shea V (1987) Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 47:258–260
Noyes R, Hoehn-Saric R (1998) The anxiety disorders. Cambridge University Press, Cambridge
Patten SB, Love EJ (1997) Drug-induced depression. Psychother Psychosom 66:63–73
Pauli P, Wiedemann G, Dengler W et al. (1999) Anxiety in patients with an automatic implantable cardioverter defibrillator: What differentiates them from panic patients? Psychosom Med 61:69–76
Perez-Stable WJ, Miranda J. Munoz RF et al. (1990) Depression in medical outpatients: Underrecognition and misdiagnosis. Arch Int Med 150:1983–1988
Perkins D, Evans DL (1991) HIV-related major depression. Psychosomatics 32:451–454
Popkin MK, Callies AL, Mackenzie TB (1985) The outcome of antidepressant use in the medically ill. Arch Gen Psychiatry 42:1160–1166
Popkin MK, Callies AL, Lentz RD et al. (1988) Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing Type I diabetes mellitus. Arch Gen Psychiatry 45:64–68
Popkin MK, Callies AL, Colon EA et al. (1990) Adjustment disorders in medically ill patients referred for consultation at a university hospital. Psychosomatics 31:410–414
Prigerson HG, Shear K, Frank E et al. (1997) Traumatic grief: A case of loss-induced trauma. Am J Psychiatry 154:1003–1008
Rabkin JG, Rabkin R, Harrison W et al. (1994) Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV infection. Am J Psychiatry 151:516–523
Reding MJ, Orto LA, Winter SW et al. (1986) Antidepressant therapy after stroke. Arch Neurol 43:763–765
Regan W, Margolin R, Mathew R (1989) Cardiac arrhythmia following rapid imipramine withdrawal. Biol Psychiatry 25:482–484
Reifler BV, Teri L, Raskind M et al. (1989) Double-blind trial with imipramine in Alzheimer’s disease patients with and without depression. Am J Psychiatry 146:45–49
Richardson JL, Zarnegar Z, Bisno B, Levine A (1990) Psychosocial status at initiation of cancer treatment and survival. J Psychosom Res 34:189–201
Ries RK, Gilbert DA, Katon W (1984) Tricyclic antidepressants in the therapy for peptic ulcer disease. Arch Intern Med 144:566–569
Rifkin A, Reardon G, Siris S et al. (1985) Trimipramin in physical illness with depression. J Clin Psychiatry 46:4–8
Robertson MM, Trimble MR (1985) The treatment of depression in patients with epilepsy. J Affect Disord 9:127–136
Robertson MM, Trimble MR Townsend HRA (1987) Phenomenology of depression in epilepsy. Epilepsia 28:364–372
Robbins E, Guze S (1972) Classification of affective disorders. In: Williams T, Katz M, Shields A (eds) Recent advantages in the psychobiolgy of the depressive illnesses. Government Printing Office, Washington/DC
Robinson RG, Starr LB, Kubos KL et al. (1983) A two-year longitudinal study of post-stroke mood disorders: Findings during the initial evaluation. Stroke 14:736–741
Robinson RG (1998) The clinical neuropsychiatry of stroke. Cognitive, behavioral and emotional disorders following vascular brain injury. Cambridge University Press, Cambridge
Rodin G, Voshart K (1986) Depression in the medically ill. Am J Psychiatry 143:696–705
Rodin R, Craven J, Littlefield C (1991) Depression in the medically ill. An integrated approach. Brunner/Mazel, New York
Roose SP, Glassman A, Giardina E (1987) Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 44:273–275
Roose SP, Laghrissi-Thode F, Kennedy JS et al. (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279:287–291
Rotzinger S, Bourin M, Akimoto Y, Coutts RT, Baker GB (1999) Metabolism of some „second“-and „fourth“-generation antidepressants: Iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine. Cell Mol Neurobiol 19(4):427–442
Rubey RN, Lydiard RB (1994) Psychopharmacology in the medically ill. In: Silver P (ed) Psychotropic drug use in the medically ill. Adv Psychosom Med, vol 21. Karger, Basel, pp 1–27
Saran AS (1985) Depression after minor closed head injury. J Clin Psychiatry 46:335–338
Satel SL, Nelson JC (1989) Stimulants in the treatment of depression. A critical overview. J Clin Psychiatry 50:241–249
Satlin A (1998) The comorbidity of depression and medical illness in the elderly. In: Tohen M (ed) Comorbidity in affective disorders. Dekker, New York Basel, pp 157–178
Schag CAC, Heinrich RL (1989) Anxiety in medical situations: Adult cancer patients. J Clin Psychology 45:20–27
Schelling G, Scholl C, Haller M et al. (1998) Health-related quality of life and post-traumatic stress disorder in survivors of the acute respiratory distress syndrome (ARDS). Crit Care Med 26:651–659
Schenker S, Bergstrom R, Wolen R et al. (1988) Fluoxetine disposition and elimination in cirrhosis. Pharmacol Ther 44:353–359
Schiffer RB, Wineman NM (1990) Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147:1493–1497
Schiffer RB, Herndon RM, Rudick RA (1985) Treatment of pathological laughing and weeping with amitryptiline. N Engl J Med 312:1480–1482
Schmale AH (1979) Reactions to illness. Psychiatr Clin North Am 2:321–330
Schulberg HC, Saul M, McClelland M (1985) Assessing depression in primary medical and psychiatric practices.Arch Gen Psychiatry 12:1164–1170
Schüßler G (1998) Krankheitsbewältigung und Psychotherapie bei körperlichen und chronischen Erkrankungen. Psychotherapeut 43:382–390
Schwab JJ, McGinness NH, Marder L et al. (1966) Evaluation of anxiety in medical patients. J Chron Dis 19:1049–1057
Schwartz JA, Speed N, Clavier E (1988) Tricyclic antidepressants in treatment of the medically ill: The value of psychiatric consultation. Int J Psychiatry Med 18:235–241
Schwartz JA, Speed N, Beresford TP (1989) Antidepressants in the medically ill: Prediction of benefits. Int J Psychiatry Med 19:363–369
Secor JW, Schenker S (1987) Drug metabolism in patients with liver disease. Adv Intern Med 32:379–406
Sellers EM, Bendayan R (1987) Pharmacokinetics of psychotropic drugs in selected patient populations. In: Meltzer HY (ed) Psychopharmacology: The third generation of progress. Raven, New York, pp 1397–1406
Shakin EJ, Holland J (1988) Depression and pancreatic cancer. J Pain Symptom Manage 3:194–198
Sharpe M, Hawton K, Seagrott V et al. (1994) Depressive disorders in long-term survivors of stroke. Br J Psychiatry 164:380–386
Sherbourne CD, Jackson CA, Meredith LS et al. (1996) Prevalence of comorbid anxiety disorders in primary care outpatients. Arch Fam Med 5:27–34
Sliman RJ, Donahue TA, Jarjoura D et al. (1992) Recognition of depression by internal medicine residents. J Community Health 17:143–152
Sonino N, Fava GA, Belluardo P et al. (1993) Course of depression in Cushing’s syndrome: Response to treatment and comparison with Graves’ disease.Horm Res 39:202–206
Spiegel D (1991) Psychosocial aspects of cancer.Curr Opin Psychiatry 4:889–897
Spiegel D (1994) Krebs und Depression. Verhaltenstherapie 4:81–88
Spiegel D, Lazar SG (1997) The need for psychotherapy in the medically ill. Psychoana Inquiry (Suppl) 17:45–50
Spiegel D, Bloom JR, Kraemer HC et al. (1989) Effect of psychological treatment on survival of patients with metastatic breast cancer. Lancet ii:888–889
Starkman MN, Zelnik TC, Nesse TC et al. (1985) Anxiety in patients with pheochromocytomas. Arch Intern Med 145:248–252
Starkstein SE, Robinson RG (1989) Affective disorder and cerebral vascular disease. Br J Psychiatry 154:170–182
Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG (1990) Depression in parkinson’s disease. J Nerv Ment Dis 178:27–31
Stefanek ME, Shaw A, DeGeorge D et al. (1989) Illness-related worry among cancer patients: Prevalence, severity and content. Cancer Invest 7:365–371
Stoudemire A, Atkinson P (1988) Use of cyclic antidepressants in patients with cardiac conduction disturbances. Gen Hosp Psychiatry 10:389–397
Stoudemire A, Hales RE (1991) Psychological and behavioral factors affecting medical conditions and DSM-IV. Psychosomatics 32:5–13
Stoudemire A, Moran MG, Fogel BS (1990) Psychotropic use in the medically ill: Part I. Psychosomatics 31:377–391
Stoudemire A, Fogel BS, Gulley LR (1991) Psychopharmacology in the medically ill: An update. In: Stoudemire A, Fogel BS (eds) Medical psychiatric practice. American Psychiatric Press, Washington/DC London, pp 29–97
Strian F, Ploog D (1988) Anxiety related to nervous system dysfunction. In: Noyes R, Roth M, Burrows GD (eds) Handbook of anxiety 2. Elsevier, Amsterdam, pp 431–475
Surman O (1991) Hemodialysis and renal transplantation. In: Cassem N (ed) Massachusetts General Hospital Handbook of General Hospital Psychiatry, 3rd edn. Mosby Year Book, St. Louis/MO, pp 401–430
Tarter RE, Switala J, Carra J et al. (1987) Inflammatory bowel disease: Psychiatric status of patients before and after disease onset. Int J Psychiatry Med 17:173–181
Thompson WL, Thompson TL (1984) Treating depression in asthmatic patients. Psychosomatics 25:809–812
Thompson WL, Thompson TL (1993) Pulmonary disease. In: Stoudemire A, Fogel B (eds) Psychiatric care of the medical patient. Oxford University Press, New York, pp 591–610
Troy S, Schultz R, Parker V et al. (1994) The effect of renal disease on the disposition of venlafaxine. Clin Pharmacol Ther 56:14–21
Trzepacz PT, McCue M, Klein I et al. (1988) A psychiatric and neuropsychological study of patients with untreated Graves’ disease. Gen Hosp Psychiatry 10:49–55
Trzepacz PT, Brenner R, van Thiel DH (1989) A psychiatric study of 247 liver transplantation candidates. Psychosomatics 30:147–153
Veith RC, Raskind MA, Caldwell JH et al. (1982) Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med 306:954–959
Wells KG, Golding JM, Burnham MA (1988) Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 145:976–981
Wells KB, Golding JM, Burnam MA (1989) Affective substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Gen Hosp Psychiatry 11:320–327
Whitlock FA (1982) Symptomatic affective disorders. Academic Press, Sydney
Wilson RCD (1974) Antiasthmatic effect of amitriptyline. Can Med Assoc J 3:212
Winokur G (1990) The concept of secondary depression and its relationship to comorbidity. Psychiatr Clin North Am 13:567–583
Winokur G, Black DW, Nashrallah A (1988) Depressions secondary to other psychiatric disorders and medical illnesses. Am J Psychiatry 145:233–237
Wolfersdorf M (1993) Suizidalität bei Tumor-und anderen körperlichen Erkrankungen. In: Staab HJ, Ludwig M (Hrsg) Depression bei Tumorpatienten. Thieme, Stuttgart New York, S 49–67
Yates WR, Bowers WA (2000) Cognitive therapy in the medicalpsychiatric patient. In: Stoudemire A, Fogel BS, Greenberg DB (eds) Psychiatric care of the medical patient. 2nd edn. Oxford University Press, Oxford, pp 51–60
Zaubler T, Katon W (1998) Panic disorder in the general medical setting. J Psychosom Res 44:25–42
Zisook S, Paulus M, Shuchter SR, Judd LL (1997) The many faces of depression following spousal bereavement. J Affect Disord 45:85–95
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Kapfhammer, HP. (2003). Depressiv-ängstliche Störungen bei somatischen Krankheiten. In: Möller, HJ., Laux, G., Kapfhammer, HP. (eds) Psychiatrie und Psychotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27386-7_62
Download citation
DOI: https://doi.org/10.1007/3-540-27386-7_62
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25074-6
Online ISBN: 978-3-540-27386-8
eBook Packages: Springer Book Archive